Evidence map›Paper›PMID 29881543›Full record

ArticleAntimicrobial resistance and infection control2018

Whole genome sequence revealed the fine transmission map of carbapenem-resistant

Wenjun Sui, Haijian Zhou, Pengcheng Du, Lijun Wang, Tian Qin, Mei Wang, Hongyu Ren, Yanfei Huang, Jing Hou, Chen Chen and 1 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Antimicrobial Resistance and Virulence Characteristics ofPathogens (Basel, Switzerland) · 2022
    Article
  7. Tracking the Outbreak of Carbapenem-ResistantInfection and drug resistance · 2022
    Article
  8. Ceftazidime-avibactam based combinations against carbapenemase producingComputational and structural biotechnology journal · 2022
    Article
  9. Article
  10. Article
  11. Transmission Dynamics of Carbapenem-ResistantFrontiers in microbiology · 2021
    Article
  12. An Outbreak of Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Genomic Epidemiology of an Outbreak ofInfection and drug resistance · 2020
    Article
  17. Emergence of an NDM-5-ProducingInfection and drug resistance · 2020
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenjun Sui *1Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
Haijian Zhou *2State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206 China.
Pengcheng Du *4Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015 China.
Lijun Wang1Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
Tian Qin2State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206 China.
Mei Wang1Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
Hongyu Ren2State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206 China.
Yanfei Huang1Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
Jing Hou5Surgical Intensive Care Unit, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
Chen Chen4Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015 China.
Xinxin Lu1Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenem-resistant Methods: Collecting case information, active screening and targeted environmental monitoring were carried out. The antibiotic susceptibility, drug-resistant genes, molecular subtype and whole genome sequence of CRKP strains were analyzed. Results: Between October and December 2011, 26 CRKP isolates were collected from eight patients in a surgical intensive care unit and subsequent transfer wards of Beijing Tongren hospital, China. All 26 isolates harbored Conclusions: This study provided the first report confirming an outbreak caused by

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsChinaCritical CareCross InfectionDisease OutbreaksDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldGenome, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase CTX-M-15beta-lactamase KPC-2, Klebsiella pneumoniaebeta-lactamase PIT-2beta-LactamasescarbapenemaseCarbapenemsCarbapenemasesKPC-2K. pneumoniaeOutbreakWhole genome sequencing

Identifiers

PMID29881543
PMCPMC5984795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.